Rose‐Mary Boustany

Author

Rose‐Mary Boustany

Also Known As

Boustany, Rose-Mary, Craig Blackstone, R Boustany, R. Boustany, Rose-Mary Boustany, Rose-Mary N Boustany, Rose-Mary N. Boustany, Rose-Mary Naaman Boustany, Rosemary Boustany, Rosemary N. Boustany

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Duke University Hospital Duke University American University of Beirut American University of Beirut Medical Center

About

Rose‐Mary Boustany is an author at Duke Medical Center specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Education	2	2	103
3	Natural Sciences	2	2	156
4	Public Health	2	2	84
5	Nursing	1	1	56

Rose‐Mary Boustany

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Isolation of a novel gene underlying batten disease, CLN3 Terry J. Lerner, Rose‐Mary Boustany, John W. Anderson, Cell Batten DiseaseGenetic DisorderGeneticsPathogenesisMolecular Genetics	1995	598
Functional genome-wide siRNA screen identifies KIAA0586 as mutated in Joubert syndrome Susanne Roosing, Matan Hofree, Sehyun Kim, eLife	2015	120
Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin Rose‐Mary Boustany, June R. Aprille, John Halperin, Annals of Neurology	1983	113
Apoptosis as the Mechanism of Neurodegeneration in Batten's Disease Steven C. Lane, R.D. Jolly, Donald E. Schmechel, Journal of Neurochemistry	1996	106
CLN3 Defines a Novel Antiapoptotic Pathway Operative in Neurodegeneration and Mediated by Ceramide Kasturi L. Puranam, Wei‐Xing Guo, Kave Nikbakht, Molecular Genetics and Metabolism Neurodegenerative DiseasesNeuroregenerationCell DeathDegenerative PathologyNeuroprotection	1999	103
Allopregnanolone attenuates N -methyl- d -aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture Ellen M. Lockhart, David S. Warner, Robert D. Pearlstein, Neuroscience Letters Oncogenic AgentMedicineApoptosisCell DeathAnti-cancer Agent	2002	93
Clinical classification of neuronal ceroid-lipofuscinosis subtypes Rose‐Mary Boustany, Joseph Alroy, Edwin H. Kolodny, American Journal of Medical Genetics	1988	90
The CLN9 Protein, a Regulator of Dihydroceramide Synthase Angela Schulz, Talal Mousallem, Maya Venkataramani, Journal of Biological Chemistry ApoptosisMolecular BiologyPathologyCell DeathChemical Biology	2005	88
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant Angela Schulz, Sumeer Dhar, Svetlana N. Rylova, Annals of Neurology	2004	77
Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3‐ and CLN2‐deficient neurons Sumeer Dhar, Rhonda L. Bitting, Svetlana N. Rylova, Annals of Neurology	2002	75

Page 1